Core Insights - Enhanced has launched its personalized performance medicine and supplement platform, starting with its proprietary Stronger and Longer supplement lines, and aims to become a leading provider in personalized enhancement products for health, performance, and recovery [1][2] Product Launch and Expansion - The company is expanding its product catalog to include peptides, anticipating regulatory changes that may allow 14 peptide compounds to be reclassified, thus creating significant revenue opportunities in a market projected to grow from $52 billion to $87 billion by 2035 [2][3] - Currently, the Live Enhanced platform offers Sermorelin and plans to introduce three additional peptides: Tesamorelin, Glutathione, and Oxytocin, with potential for eight more based on regulatory approvals [3] Targeted Protocols - Enhanced is developing female-specific performance protocols in collaboration with experts from Dama Health, addressing a significant gap in performance medicine and consumer health for women [4] Competitive Advantage - The company is conducting a clinical trial with 40 elite athletes to gather proprietary data on the safety and performance of certain medical compounds, which will inform product development and differentiation in the consumer market [6] Business Strategy - Enhanced aims to revolutionize the performance medicine category by leveraging proprietary data from athlete trials and focusing on personalized offerings, which provides a competitive edge over standardized products [2][5] Upcoming Events - The inaugural Enhanced Games, scheduled for May 24, 2026, will emphasize scientific innovation and athlete welfare, offering substantial financial incentives to participants [8]